Effective for fill dates on or after Jan. 1, 2025, a new medical benefit step therapy program will apply for Harvard Pilgrim Health Care Commercial products, Tufts Health Plan Commercial products, Tufts Health Direct, and Tufts Health Together. The goal of the program is to encourage the use of the least costly alternatives across a variety of therapeutic areas. The new coverage requirements will apply to patients initiating therapy with a non-preferred product.
Preferred and non-preferred products associated with the medical benefit step therapy program for Commercial products and Tufts Health Direct are as follows:
Drug class | Non-preferred product(s) | Preferred product(s) |
Acromegaly
|
Signifor LAR
Somatuline Depot |
lanreotide
lanreotide (cipla) Sandostatin LAR
|
Antiemetics | Akynzeo
Aponvie Cinvanti Emend Focinvez Sustol |
fosaprepitant
granisetron ondansetron palonosetron
|
Bendamustine HCI Injection | Bendeka
Treanda Vivimusta |
bendamustine
Belrapzo |
Iron Preparation, Parenteral | Feraheme
Injectafer Monoferric |
Ferrlecit
Infed Venofer |
Leucovorin / LEVOleucovorin Injection | Fusilev
Khapzory LEVOleucovorin |
leucovorin injection |
Pemetrexed | Alimta
Pemfexy Pemrydi |
Pemetrexed (all manufacturers) |
Retinal Disorders | Beovu
Byooviz Cimerli Eylea Lucentis Susvimo Visudyne |
Avastin |
Eylea HD
Vabysmo |
Avastin
Eylea Ranibizumab |
|
Triamcinolone Acetonide Injection | Zilretta | Triamcinolone acetonide injection |
For Tufts Health Together, the following will apply:
Drug Class | Non-preferred product(s) | Preferred product(s) |
Antiemetics | Akynzeo
Aponvie Cinvanti Emend Focinvez Sustol |
fosaprepitant
granisetron ondansetron palonosetron
|
Iron Preparation, Parenteral | Feraheme
Injectafer Monoferric |
Ferrlecit
Infed Venofer |
Leucovorin / LEVOleucovorin Injection | Fusilev
Khapzory LEVOleucovorin |
leucovorin injection |
Pemetrexed | Alimta
Pemfexy Pemrydi |
Pemetrexed (all manufacturers) |
Triamcinolone Acetonide Injection | Zilretta | Triamcinolone acteonide injection |
For more information, please refer to our Medical Benefit Step Therapy Program Medical Necessity Guidelines (MNG) for Harvard Pilgrim Commercial, Tufts Health Plan Commercial, and Tufts Health Direct, as well as the equivalent MNG for Tufts Health Together, which you can find on the Medical Benefit Drug Medical Necessity Guidelines page on Point32Health’s provider website.
Annmarie Dadoly,
Senior Manager, Provider Communications
Joseph O’Riordan,
Editor
Susan Panos, Ellen Gustavson, Ryan Francis, Stephen Wong,
Writers
Kristin Edmonston,
Production Coordinator
Kristina Cicelova,
Graphic Designer